Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
Trends in Pharmacological Sciences · 2024-10 · 45 (10) · 892-903
DOI: 10.1016/j.tips.2024.08.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2024-10. Verfasst von Phurpa Wangchuk und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Public Health, Medical, and Veterinary Sciences (CPHMVS), Cairns campus, James Cook University, QLD 4878, Australia; Australian Institute …. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Biomarkers. Die Arbeit wurde bisher 366-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Public Health, Medical, and Veterinary Sciences (CPHMVS), Cairns campus, James Cook University, QLD 4878, Australia; Australian Institute of Tropical Health and Medicine (AITHM), Cairns campus, James Cook Uni…
- Australian Institute of Tropical Health and Medicine (AITHM), Cairns campus, James Cook University, QLD 4878, Australia.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Wangchuk, P., Yeshi, K., & Loukas, A. (2024). Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends in Pharmacological Sciences, 45(10), 892-903. https://doi.org/10.1016/j.tips.2024.08.003
Vancouver
Wangchuk P, Yeshi K, Loukas A. Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends in Pharmacological Sciences. 2024;45(10):892-903. doi:10.1016/j.tips.2024.08.003
BibTeX
@article{Wangchuk2024,
author = {Wangchuk, Phurpa and Yeshi, Karma and Loukas, Alex},
title = {Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments},
journal = {Trends in Pharmacological Sciences},
year = {2024},
volume = {45},
number = {10},
pages = {892--903},
doi = {10.1016/j.tips.2024.08.003}
}
EUVIMED